From July 12 to 14, 2024, the 21st Annual Meeting of the Endocrinology Branch and the 5th Annual Meeting of the Diabetes Branch of the Anhui Provincial Medical Association was held in Hefei City. This meeting was jointly organized by the Anhui Medical Association, the Endocrinology Branch of the Anhui Medical Association and the Diabetes Branch of the Anhui Medical Association, and hosted by the First Hospital Affiliated to the University of Science and Technology of China (Anhui Provincial Hospital), which attracted many endocrinology and diabetes specialists and scholars from all over the province and even the country to participate in the meeting. PinYuan Medical brought its dual-energy X-ray bone densitometer Dexa Pro-I to the event, adding new technological highlights to the meeting.
This annual meeting aims to promote academic exchanges and cooperation in the field of endocrinology and diabetes, and discuss the latest research progress and hot issues in this field. During the meeting, renowned experts from inside and outside the province conducted in-depth presentations and continuing education lectures on hot issues in endocrinology and diabetology. Of particular interest is that the experts paid great attention to the issue of diabetes and osteoporosis co-morbidity. According to statistics, the prevalence of osteoporosis among T1DM patients is as high as 48%-72%, and the combined prevalence of osteoporosis among T2DM patients in mainland China also reaches 37.8%, and this percentage increases with age. This data highlights the severity of the co-morbidity between diabetes and osteoporosis, and suggests that clinicians need to pay more attention to the correlation and interplay between the two in the diagnosis and treatment process.
In response to this issue, experts offered their insights and suggestions. They emphasized the importance of early diagnosis, comprehensive treatment and patient education, and believed that the risk of diabetes and osteoporosis co-morbidities and the incidence of complications can be effectively reduced through multidisciplinary collaboration, the development of personalized treatment plans and the enhancement of patient self-management.
As a professional manufacturer of bone densitometers, PYM presented its dual-energy X-ray bone densitometer Dexa Pro-I at the conference and became a bright landscape at the venue. Dexa Pro-I won high attention and praise from the experts at the conference for its accurate detection capability, efficient workflow and humanized design concept. The device not only provides strong support for the early diagnosis of osteoporosis and other diseases, but also provides a scientific basis for clinical decision-making, further promoting the innovation and development of medical technology in the fields of endocrinology and diabetes.
Dexa Pro-I Dual Energy X-Ray Bone Densitometer is a high-end medical device independently developed by PinYuan Medical, which is mainly used for the early diagnosis and evaluation of osteoporosis and other bone diseases. The device adopts advanced dual-energy X-ray technology, which can accurately measure the bone density and bone quality of human bones. Meanwhile, its convenient operation and humanized design greatly improve the testing efficiency and patient comfort.
The success of this annual meeting not only promotes the academic exchange and cooperation in the field of endocrinology and diabetes, but also provides a stage for PinYuan Medical to show its strength. In the future, PYM will continue to innovate and develop to provide medical institutions with more high-quality and efficient medical equipment and services.
Post time: Jul-24-2024